Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy.

Biotechnology

Immutep

Immutep's headquarters in Sydney, Australia

Marc Voigt

Frédéric Triebel

Christian Mueller

Deanne Miller

Martine J. Piccart

Martin Forster

Scott Antonia

Leisha A Emens

Hans Wildiers

Russell Howard

Lis Boyce

Salah-Eddin Al-Batran

Pete Meyers

The Clinical Operations team at Immutep is responsible for the planning, execution, and management of clinical trials related to cancer immunotherapy. This team oversees trial protocols, ensures compliance with regulatory standards, manages clinical supplies, and coordinates with contracts and vendors to facilitate the smooth operation of studies. Through their expertise, the team aims to drive innovative research and improve patient outcomes in cancer treatment.

Clinical Operations

The Leadership Team at Immutep is responsible for shaping the strategic direction of the company, overseeing regulatory compliance, and driving scientific innovation in cancer immunotherapy. Comprising executive leaders in areas such as regulatory affairs, medical science, and business development, this team collaborates to enhance the company’s research initiatives, ensure legal and operational integrity, and effectively communicate the company’s vision and goals to stakeholders.

Leadership Team

The Regulatory and Quality Assurance team at Immutep plays a crucial role in ensuring that all products and processes comply with industry regulations and quality standards. They oversee the development and submission of regulatory documents, manage quality assurance protocols, and collaborate with other departments to maintain adherence to best practices in the development of cancer immunotherapy solutions. Their efforts help ensure the safety and efficacy of Immutep's innovative therapies.

Regulatory and Quality Assurance

The Research and Development team at Immutep focuses on advancing cancer immunotherapy solutions through innovative research in immunology. Comprised of experts in inflammation and immuno-oncology, the team conducts pre-clinical and clinical studies to develop novel therapeutic strategies aimed at enhancing the body’s immune response against cancer. Their collaborative efforts aim to translate scientific discoveries into effective treatments for cancer patients.

��

Immutep

Org chart

Board & advisors

Teams

Clinical Operations

Leadership Team

Regulatory and Quality Assurance

Research and Development

Offices

��������

Immutep

Org chart

Board & advisors

Teams

Clinical Operations

Leadership Team

Regulatory and Quality Assurance

Research and Development

Offices

Related companies

��